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Acute and late toxicity were scored using the EORTC/RTOG 
radiation morbidity score system. Both patient and physician 
recorded cosmetic outcome evaluation with a subjective 
judgment scale at the time of scheduled follow-up. 
Results: The median follow-up was 24 months (range 19 - 36 
months). The acute skin grade toxicity during the treatment 
was G0 in 10 patients (6.7%), G1 in 105 (70%), G2 in 35 cases 
(23.3%). No grade 3 or higher acute skin toxicity was 
observed. At 12 months, skin toxicity was G0 in 105 (70%), G1 
in 45 (30%). No toxicity ≥ G2 was registered. At 24 months 
skin toxicity was G0 in 130 (86%), G1 in 20 (14%). No case ≥ 
G2 was registered.  
The pre-treatment variables correlated with skin grade G2 
acute toxicity were adjuvant chemotherapy (p=0.01) and 
breast volume ≥ 700 cm3 (p= 0.001). Patients with an acute 
skin toxicity grade 2 had a higher probability to develop late 
skin toxicity (p<0.0001). In the 98% of cases, patients were 
judged to have a good or excellent cosmetic outcome. The 2-
year-Overall Survival and 2-year-Local Control were 100%. 
Conclusions: These data support the feasibility and safety of 
SIB-IMRT in patients with a diagnosis of breast cancer 
following BCS with acceptable acute and late treatment-
related toxicity. A longer follow-up is needed to define the 
efficacy on outcomes. 
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Purpose/Objective: To determine individual variability of 
axillary sentinel lymph nodes (SLN) localization in patient 
with breast cancer (BC) and to evaluate clinical value of 
SPECT-CT with radiocolloids for field design and treatment 
planning 
Materials and Methods: Individual topography of axillary SLN 
was determined in 127 patients with early BC. All women 
were candidates for conservative surgical treatment with 
postoperative radiotherapy. SPECT-CT visualization of SLN 
started 120-240 min after intratumoral injection of 74-
150MBq of 99mTc-radiocolloids. Distribution of axillary SLN 
was allocated to following subregions: central (C), anterior 
pectoral (AP), sub-(SP) intrapectoral (IP), lateral (L), 
subscapular (SSc), LN 'lying on the ribs' (Th).  
During the second part of the study we used routine 3D plans 
for standard tangential fields and contoured on this plans SLN 
of each axillary subregion. The same procedure was repeated 
for individually shaped extended tangential fields with upper 
border on the lower border of the humeral head. At the end, 
for SLN localized in Th subregion we tested intensity 
modulated radiation therapy (IMRT) treatment plans 
Results: SPECT-CT visualization of SLN demonstrated large 
variability in their localization. In most cases they were 
detected in C (64 observations, 50.5%) and AP (34 women, 
26.8%) subregions. In 19 (14.9%) cases SLN were revealed in 
Th and in another 10 (7.8%) patients –in L or SSc subregions. 
In 17 (13.4%) women SLN were localized both on I and II (IP, 
SP) levels. 
3D modeling of dose distribution obtained with different 
radiotherapy techniques help us to evaluate coverage of SLN 
localized in various axillary subregions. We found that our 
standard tangential fields do not cover SLN in 80% cases. In 
20% they encompass C, AP, IP, SP nodes. Slight modification 
of tangential fields permit effective irradiation of C, AP, IP, 
SP, L, SSc nodes in all cases. Th LN can be covered only with 
the help of IMRT 
Conclusions: SPECT-CT localization of SLN is an important 
part of radiotherapy planning in patients with early BC. 
SPECT-CT results advocate application of standard tangential 
fields in 20%, extended tangential fields – in 65.1% and IMRT – 
in remained 14.9% of evaluated patients  
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Purpose/Objective: Breast cancer radiotherapy has been 
associated with an increased risk of coronary disease. 
According to literature the amount of calcium deposits in the 
coronary arteries (CAC scores) predicts the risk of subsequent 
cardiovascular events, even without symptomatic Coronary 
Artery Disease [Greenland 2007; Oudkerk 2008; Kavousi 
2012]. However, no data are available on the amount of 
Coronary Artery Calcium (CAC) in the coronary arteries 
before and after radiotherapy for breast cancer. Therefore, 
CAC scores were prospectively determined to identify 
differences in CAC scores between three groups of breast 
cancer patients by comparing them before the start of 
radiotherapy and three years after radiotherapy.  
Materials and Methods: Ninety-nine consecutive patients 
with breast cancer referred for radiotherapy after breast 
conserving surgery were included in our study. Their 
cardiovascular risk-profile was registered, and 64multi-slice 
CT-scans were performed at baseline and three years after 
radiotherapy. 
The patients were subdivided in three groups: left- and right-
sided radiotherapy, and left-sided radiotherapy using a 
breath-hold technique. The differences in increase of the 
overall and Left Anterior Descending (LAD) CAC scores were 
determined. Within each patient also LAD-RCA scores were 
analyzed, representing CAC scores of the LAD coronary artery 
minus those of the Right Coronary Artery (RCA). 
Results: After three years, a non-significant lower increase in 
overall CAC scores and a significant lower increase in mean 
CAC scores in the LAD was found for the group with left-sided 
breast cancer treated with breath-hold compared to the 
group without breath-hold. Furthermore, the LAD-RCA scores 
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in patients treated for left-sided breast cancer without 
breath-hold were higher when compared to those with right-
sided breast cancers and to those with left-sided breast 
cancer treated with breath-hold. See the Table and the 
Figure. 
Group 
Mean CAC  
LAD_baseline 
Mean CAC  
Overall_baseline  
Mean CAC  
LAD_3 years 
Mean CAC  
Overall_3 years  
R (n=20) 14.5 (0-105) 80.1 (0-825) 
 
29.9 (0-255) 138 (0-1334) 
 
L-BH (n=18) 49.3 (0-334) 75.2(0-477) 
 
77.3 (0-634) 138.3 (0-1055) 
 
L+BH (n=61) 19.3 (0-401) 35.7 (0-645) 
 
28.8 (0-509) 64.9 (0-1039) 
 
 
 
 
Figure left and middle: Mean calcium score increase in time 
for the LAD and overall CAC score. Figure right: Mean CAC 
score: LAD minus RCA. 
Blue solid line: Left-sided breast cancer patients, group L-BH. 
Black dashed line: Right-sided breast cancer patients, group 
R. Red dotted line: Left-sided breast cancer patients treated 
in breath-hold, group L+BH. Note: the scales in the figure 
differ. 
Conclusions: Breath-hold in breast conserving radiotherapy 
leads to a less pronounced increase of CT based CAC scores. 
Therefore, breath-hold is probably useful to prevent the 
development of radiation-induced coronary artery disease. 
The drawbacks of our study were the small numbers and the 
relatively short follow-up period. 
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Purpose/Objective: Loco-regional recurrences in post-
irradiated breast cancers pose a major therapeutic challenge 
and could severely compromise patients' quality of life. Since 
in most cases, patients usually have co-existing systemic 
disseminated disease, a sustainable complete local regression 
of the recurrences, without treatment induced morbidity 
could provide an effective palliation and improve theirquality 
of life. Local hyperthermia (HT) along with moderate doses 
of re-irradiation (ReRT)has been used in various single-arm 
(ReRT+HT) and two-arm clinical trials (randomized and 
nonrandomized, ReRTvs. ReRT+HT). The present study 
conducts a systematic review and meta-analysis on the 
outcome of these trials. 
Materials and Methods: Using the appropriate MeSH and 
Boolean function, a detailed search was conductedas per the 
PRISMA guidelines. 2,047 abstracts were screenedfrom the 10 
databases used for search (Fig). Only those studies which had 
received prior loco-regional RT as a part of their primary 
management and were treated with ReRT and HT alone were 
considered. Patients who had undergone surgery for the loco-
regional recurrences were subjected to concurrent 
chemotherapy were not considered. End point evaluation was 
complete loco-regional response (CR) following ReRT and HT.  
 
 
Results: A total of 43 full papers were shortlisted and 
reviewed after extensive database search, and 24studies 
were selected for detailed review based on pre-defined 
selection criteria. Six of these were two-arm (randomized, 
n=4; nonrandomized, n=2) while 18 were single-arm studies 
resulting in a total of 1,319 patients of which 1,162 received 
ReRT and HT.  
Primary RT at doses ranging from 40 to60 Gy (mean + SD: 
50.6+ 6.1 Gy) was received by these patients between 37 and 
72 months before being considered for ReRT. Hyperthermia 
was mostly delivered by microwaves (91.7%), twice a week 
and usually following RT (79.2%). A temperature ranging from 
40.6 -43°C (42.4+ 0.7°C) was achieved during HT which 
lasted for a mean duration of 53.5 min. ReRT doses ranged 
from 24 -60 Gy (36.3 +8.1Gy) and delivered at 1.8 to 4 Gy/fr 
(2.85+0.9 Gy). 
Two-arm studies included 494 patients, and a CR of 62.8% 
and 39.3% was observed with ReRT+HT and ReRTrespectively, 
giving an odds ratio of 2.9 (95% CI: 1.8-4.6, p<0.001; Q=6.4, 
I2= 22.2, p=0.26). The risk ratio was 1.6 (95% CI: 1.2-2.0) in 
favor of achieving a CR with ReRT+HT compared to ReRT 
alone. For 18 single-arm studies, a CR of 64.6% was reported 
from the 825 patients resulting in an event rate of 0.6 (95% 
CI: 0.5-0.6, p<0.001; Q=33.8, I2= 49.7, p=0.008). Local 
control with ReRT +HT at 1 and 2 year were 57.1% and 48.5% 
respectively. Mean acute and late grade III/IV toxicities with 
ReRT +HT were reported as 13.4% and 3.9%. 
Conclusions: ReRT with HTsubstantially increases the 
probability of achieving CRs in loco-regional recurrences in 
pre-irradiated patients with low acute and late morbidities.  
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